Ohio Governor Mike DeWine, along with Hikma Pharmaceuticals, JobsOhio, the City of Bedford, and other state and local partners, today announced plans for a significant expansion of Hikma’s manufacturing operations in Ohio, reinforcing the company’s commitment to the state’s growing pharmaceutical and biomanufacturing industry. A leading U.S. generic medication provider, Hikma will invest a total of $267 million across its Columbus and Bedford facilities, creating 350 new jobs.